TUESDAY, Sept. 21, 2021 (HealthDay News) — Potentially dangerous symptoms of type 1 diabetes in children are not always immediately recognized by primary care providers, new research suggests. In type 1 diabetes, the pancreas fails to make enough insulin, the hormone that helps regulate blood sugar used for energy byContinue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan (T-DXd), sold as Enhertu, triples the length of time that the cancer remains in check when compared with the current gold standard, trastuzumab emtansine (T-DM1).Continue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — Millions of U.S. sleep apnea patients are scrambling to find ways to protect their nightly slumber, following a voluntary recall from one of the nation’s leading manufacturers of CPAP breathing machines. Philips Respironics agreed to a voluntary recall of continuous positive airway pressureContinue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — Starting in November, the United States plans to lift travel restrictions on people coming from overseas who are fully vaccinated against COVID-19. This move by the Biden administration will open the United States to relatives separated from families as well as business travelers.Continue Reading

Here are some of HealthDay’s top stories for Monday, Sept. 20: Lower dose of Pfizer vaccine works in kids as young as 5: The pharmaceutical giant announced Monday that a dose that is one-third the strength of adult doses triggered a robust immune response in young children. Read more GoodContinue Reading